Jones Financial Companies
EBS icon

Jones Financial Companies’s Emergent Biosolutions EBS Stock Holding History

Jones Financial Companies’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.6K Sell
1,008
-20
-2% -$167 ﹤0.01% 3855
2026
Q1 		$8.15K Hold
1,028
– – ﹤0.01% 3651
2025
Q4 		$12.7K Hold
1,028
– – ﹤0.01% 3122
2025
Q3 		$9.16K Buy
1,028
+93
+10% +$723 ﹤0.01% 3115
2025
Q2 		$5.94K Buy
935
+520
+125% +$2.98K ﹤0.01% 3080
2025
Q1 		$1.93K Buy
415
+15
+4% +$124 ﹤0.01% 3249
2024
Q4 		$3.82K Hold
400
– – ﹤0.01% 2832
2024
Q3 		$3K Hold
400
– – ﹤0.01% 2578
2024
Q2 		$2.73K Buy
+400
New +$1.72K ﹤0.01% 2090

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Jones Financial Companies's EBS Position: Q2 2026 in Review

Jones Financial Companies reduced its Emergent Biosolutions (EBS) stake by 1.9% in Q2 2026, selling an estimated $167 and leaving 1,008 shares worth $8.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3855.

Jones Financial Companies first reported a position in EBS in Q2 2024 and has held it in 9 quarters since. The position peaked at $12.7K in Q4 2025. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Jones Financial Companies held 1,008 shares of Emergent Biosolutions worth $8.6K as of Q2 2026.
  • Jones Financial Companies sold 20 Emergent Biosolutions shares in Q2 2026, an estimated $167.
  • Emergent Biosolutions made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3855 holding.
  • Jones Financial Companies first reported a position in Emergent Biosolutions in Q2 2024 and has held it in 9 quarters since.
  • Jones Financial Companies's Emergent Biosolutions position peaked at $12.7K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.